| "> | | | | $1,248m in 2009 and is characterized by efficacious |
| GlobalData, the industry analysis specialist's new | | | | dental procedures such as scaling, root planing and |
| report, "Periodontal disease - Drug Pipeline Analysis | | | | surgery. The periodontal therapeutics market |
| and Market Forecasts to 2016" is an essential source | | | | comprises Local Applied Antibodies (LAAs) and |
| of information and analysis on the global periodontal | | | | systemic applied antibodies. The influx of new drugs |
| disease market. The report identifies the key trends | | | | and the increase in the uptake of LAAs will the drive |
| shaping and driving the global periodontal disease | | | | the market in the forecast period. The various |
| market. The report also provides insight on the | | | | phases of the developmental pipeline contain 19 |
| prevalent competitive landscape and the emerging | | | | molecules. Of these, only five are in Phase III and the |
| players expected to bring significant shift in the | | | | rest are in the early stages of development. The |
| market positioning of the existing market leaders. | | | | pipeline consists of no new antibiotics. The |
| Most importantly, the report provides valuable insight | | | | combinations of the tetracylines are expected to |
| on the pipeline products within the global periodontal | | | | improve the efficacy of the treatment. However, the |
| disease sector. | | | | drug is similar in nature to doxycyclines. |
| The global periodontal disease market was valued at | | | | |